AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murrill, C. S.
Right arrow Articles by Gwinn, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murrill, C. S.
Right arrow Articles by Gwinn, M.
Related Collections
Right arrow Geography
Right arrow HIV/AIDS
Right arrow Hepatitis
Right arrow Drugs
Age-Specific Seroprevalence of HIV, Hepatitis B Virus, and Hepatitis C Virus Infection Among Injection Drug Users Admitted to Drug Treatment in 6 US Cities

Christopher S. Murrill, PhD, MPH, Howard Weeks, MD, Brian C. Castrucci, BA, Hillard S. Weinstock, MD, MPH, Beth P. Bell, MD, MPH, Catherine Spruill, MS and Marta Gwinn, MD, MPH

Christopher S. Murrill, Howard Weeks, Brian C. Castrucci, and Hillard S. Weinstock are with the National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Ga. Beth P. Bell is with the Division of Viral Hepatitis, National Center for Infectious Diseases, CDC, Atlanta, Ga. Catherine Spruill is with the National Center for Infectious Diseases, CDC, Atlanta, Ga. Marta Gwinn is with the National Center for Environmental Health, CDC, Atlanta, Ga.



View larger version (18K):

[in a new window]
  		FIGURE 1— Prevalence of HIV, antibody to hepatitis B core antigen (anti-HBc), and antibody to hepatitis C virus (anti-HCV) among injection drug users admitted to drug treatment, by age group and city, 1993–1994.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Public Health Association